How Working Nurses Can Plan Their Next Career Move

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

There comes a point in many nursing careers when experience raises a new question: what next? You may enjoy patient care but want more influence over how a team operates. Perhaps teaching new nurses appeals to you, or you’ve become interested in the decisions happening beyond an individual unit. Graduate education is one possible route […]

The post How Working Nurses Can Plan Their Next Career Move appeared first on Medical News Bulletin.

Laser Phototherapy: How 308 nm UVB Treatment Works and Its Clinical Applications

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Ultraviolet phototherapy has been used in dermatology for decades. One of the more targeted approaches developed over time is 308 nm excimer phototherapy. Unlike conventional UVB treatment, which may expose a large area of skin, a targeted system directs the light only at the areas that need treatment. This can be useful when a patient […]

The post Laser Phototherapy: How 308 nm UVB Treatment Works and Its Clinical Applications appeared first on Medical News Bulletin.

Clareon PanOptix Pro reduces dysphotopsias

LONDON — The Clareon PanOptix Pro IOL improves upon the visual quality of the original PanOptix design by reducing dysphotopsias, marking a step toward improved unaided visual acuity and spectacle independence.
“I was very happy with the predecessor, Clareon PanOptix (Alcon),” Ben LaHood, MD, one of the early users of the PanOptix Pro, told Healio at the European Society of Cataract and Refractive Surgeons meeting. “It gave predictable refractive outcomes, good quality of vision and a high rate of spectacle independence, so I wasn’t sure what to expect because I was already happy with what I

Laws for equal OD-MD payments, vision benefit manager reform pass

Two new state laws address equal pay for optometrists and ophthalmologists in one state and tighten regulations on vision benefits managers in another.
“Illinois and Connecticut address different challenges, but both demonstrate the impact of AOA and affiliate sustained advocacy focused on patients and the doctors who care for them,” the American Optometric Association said in a statement to Healio. “Together, they reflect growing recognition by policymakers of optometry’s essential and expanding healthcare role and that protecting access to eye care requires both fair

Superior capsular reconstruction in massive rotator cuff tears

Click here to read the Healio Exclusive, “Plethora of options means tough decisions for massive cuff tears.”
The surgical treatment of massive posterosuperior rotator cuff tears without arthritis remains a challenge.
These tears are commonly found to be irreparable due to associated characteristics, including tear chronicity, tendon retraction, loss of tendon substance/mobility and development of associated muscle atrophy. Multiple surgical options are available to treat irreparable tears, but no single approach has proven to be superior, with management tailored to patients’ symptoms, function

Presentation acuity partially explains AML survival disparities

Black children with acute myeloid leukemia are significantly more likely to present with high cardiovascular and respiratory acuity at cancer diagnosis, which partially explains survival disparities compared with white patients.
Data from close to 800 patients also showed Black, white and Hispanic children all had similar relapse rates, indicating historic survival gaps based on race and ethnicity are not driven by differences in relapse.
“If we want to eliminate these disparities, we have to look beyond the cancer itself and really understand what’s happening across the entire care continuum,

Laser prophylaxis may lower RD rate in Stickler syndrome

MONTEREY, Calif. — Children with Stickler syndrome who underwent laser prophylaxis were significantly less likely to develop a retinal detachment vs. those who did not undergo prophylaxis, according to a poster.
Joanne Thomas, MD, of Emory Eye Center in Atlanta, and colleagues wrote that around 50% of patients with Stickler syndrome experience childhood rhegmatogenous retinal detachment (RD). The retrospective chart review, which was presented at the Women in Ophthalmology Summer Symposium, aimed to investigate the efficacy of laser prophylaxis for preventing RD in this patient population.

Society for Maternal-Fetal Medicine issues guidance for abortion care under restrictions

New guidance from the Society for Maternal-Fetal Medicine, or SMFM, states that abortion care and counseling is a core part of maternal-fetal healthcare “and cannot be separated from high-risk pregnancy care.”
According to SMFM, all patients at a higher risk for pregnancy complications should be given “accurate, evidence-based information about the health risks and all treatment options and their availability, including abortion care.”
Accurate, unbiased evidence-based counseling on prognosis and treatments, the medical society added, “is critical for pregnant patients with a fetal anomaly

A fourth unvaccinated person with measles dies in Pennsylvania

A fourth person with measles has died in Pennsylvania, the state’s health department reported on Tuesday.
In addition to confirming the death of a Jefferson County woman with measles over the weekend, state health officials announced the measles-associated death of a resident of Mifflin County in central Pennsylvania.

Jefferson County Coroner Greg Furlong told Healio on Tuesday that the 40-year-old woman who died over the weekend tested positive for measles and the state confirmed that measles was her cause of death. Furlong previously told Healio that the woman had COPD, asthma, anemia and

FDA approves Isembyld for spinal muscular atrophy

The FDA has approved Isembyld, the first and only treatment to demonstrate motor function improvement in individuals with spinal muscular atrophy who are also receiving a survival motor neuron 2-targeted treatment.
Isembyld (apitegromab-mstn, Scholar Rock) was approved for all adults and children aged 2 years and older. The muscle-targeted treatment works by binding to promyostatin and latent myostatin and inhibiting its activation, according to a press release from Scholar Rock, the biopharmaceutical company that developed the drug.
The approval of Isembyld is significant because of its